Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
J Med Chem. 2005 Jul 28;48(15):5025-37. doi: 10.1021/jm050261p.
J Med Chem. 2005.
PMID: 16033281
The dual peroxisome proliferator-activated receptor alpha/gamma activator muraglitazar prevents the natural progression of diabetes in db/db mice.
Tozzo E, Ponticiello R, Swartz J, Farrelly D, Zebo R, Welzel G, Egan D, Kunselman L, Peters A, Gu L, French M, Chen S, Devasthale P, Janovitz E, Staal A, Harrity T, Belder R, Cheng PT, Whaley J, Taylor S, Hariharan N.
Tozzo E, et al.
J Pharmacol Exp Ther. 2007 Apr;321(1):107-15. doi: 10.1124/jpet.106.115337. Epub 2007 Jan 26.
J Pharmacol Exp Ther. 2007.
PMID: 17259449
Item in Clipboard
Discovery of trifluoromethyl(pyrimidin-2-yl)azetidine-2-carboxamides as potent, orally bioavailable TGR5 (GPBAR1) agonists: structure-activity relationships, lead optimization, and chronic in vivo efficacy.
Phillips DP, Gao W, Yang Y, Zhang G, Lerario IK, Lau TL, Jiang J, Wang X, Nguyen DG, Bhat BG, Trotter C, Sullivan H, Welzel G, Landry J, Chen Y, Joseph SB, Li C, Gordon WP, Richmond W, Johnson K, Bretz A, Bursulaya B, Pan S, McNamara P, Seidel HM.
Phillips DP, et al.
J Med Chem. 2014 Apr 24;57(8):3263-82. doi: 10.1021/jm401731q. Epub 2014 Apr 4.
J Med Chem. 2014.
PMID: 24666203
Item in Clipboard
Discovery of highly potent, lung-localized epithelial sodium channel inhibitors.
Kumar M, Welzel G, Chatterjee AK.
Kumar M, et al.
Bioorg Med Chem Lett. 2015 Nov 1;25(21):4797-4801. doi: 10.1016/j.bmcl.2015.07.015. Epub 2015 Jul 14.
Bioorg Med Chem Lett. 2015.
PMID: 26235948
Item in Clipboard
Cardiovascular and metabolic effects of adenosine A1-receptor agonists in streptozotocin-treated rats.
Cox BF, Clark KL, Perrone MH, Welzel GE, Greenland BD, Colussi DJ, Merkel LA.
Cox BF, et al. Among authors: welzel ge.
J Cardiovasc Pharmacol. 1997 Mar;29(3):417-26. doi: 10.1097/00005344-199703000-00017.
J Cardiovasc Pharmacol. 1997.
PMID: 9125682
Item in Clipboard
Dissociated sterol-based liver X receptor agonists as therapeutics for chronic inflammatory diseases.
Yu S, Li S, Henke A, Muse ED, Cheng B, Welzel G, Chatterjee AK, Wang D, Roland J, Glass CK, Tremblay M.
Yu S, et al.
FASEB J. 2016 Jul;30(7):2570-9. doi: 10.1096/fj.201600244R. Epub 2016 Mar 29.
FASEB J. 2016.
PMID: 27025962
Free PMC article.
Item in Clipboard
Characterization of the renal effects and renal elimination of sulotroban in the dog.
Mann WA, Welzel GE, Goldstein RS, Sozio RS, Cyronak MJ, Kao J, Kinter LB.
Mann WA, et al. Among authors: welzel ge.
J Pharmacol Exp Ther. 1991 Dec;259(3):1231-40.
J Pharmacol Exp Ther. 1991.
PMID: 1762070
Item in Clipboard
Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation.
Constantinides PP, Welzel G, Ellens H, Smith PL, Sturgis S, Yiv SH, Owen AB.
Constantinides PP, et al.
Pharm Res. 1996 Feb;13(2):210-5. doi: 10.1023/a:1016030812272.
Pharm Res. 1996.
PMID: 8932438
Item in Clipboard
Cite
Cite